Depression and Cognitive Decline in Older Adults

Depression and cognitive decline frequently co-occur in older populations, contributing to diminished quality of life and increased healthcare burden worldwide. Late-life depression often presents alongside memory loss, slowed processing speed and difficulties in executive function. Emerging evidence indicates a bidirectional relationship whereby depressive symptoms may accelerate cognitive deterioration, while early cognitive deficits can exacerbate mood disturbances. Biological mechanisms span vascular dysfunction, neuroinflammation, hippocampal atrophy and amyloid-β accumulation, suggesting overlapping pathways with Alzheimer’s disease. Heterogeneity in symptom trajectories underscores the need for tailored assessment of mood and cognition over time. Early identification and intervention—ranging from antidepressant therapy to lifestyle modification—hold promise for mitigating risk of dementia and preserving independence in ageing individuals.

Research from Nature Portfolio

One large multinational cohort investigation characterised trajectories of depressive symptoms in over 69 000 adults aged 50 and above, identifying four distinct patterns: persistently low, persistently high, increasing and decreasing symptoms. Those with rising or consistently high depressive symptoms exhibited the steepest linear decline in immediate and delayed recall as well as verbal fluency, whereas individuals whose symptoms diminished showed relatively preserved cognition. This work emphasises that not only the presence but the dynamic course of depressive symptoms predicts the rate and shape of age-related cognitive change, pointing to specific windows for preventive interventions.

Depression and Cognitive Decline in Older Adults publication trend

The graph below shows the total number of articles in depression and cognitive decline in older adults across all publications each year (not limited to Nature Index journals).

Technical terms

Late-life depression (LLD): A depressive syndrome with onset or persistence in individuals aged 60 years and older, often accompanied by cognitive and functional impairments.

Bidirectional association: A reciprocal relationship in which two variables—here, mood symptoms and cognitive performance—influence each other over time.

Amyloid-β (Aβ): A peptide that can aggregate into plaques in the brain, implicated in neurodegenerative processes and Alzheimer’s disease pathology.

Hippocampal neurogenesis: The generation of new neurons in the hippocampus, a region critical for memory; this process may be affected by both depression and ageing.

Prodromal symptom: An early clinical sign that precedes the full onset of a disease, such as mild mood changes before dementia becomes apparent.

References

1. Trajectories of depressive symptoms and associated patterns of cognitive decline. Scientific Reports (2020).
2. Bidirectional Associations of Depressive Symptoms and Cognitive Function Over Time. JAMA Network Open (2024).
3. Is later-life depression a risk factor for Alzheimer’s disease or a prodromal symptom: a study using post-mortem human brain tissue?. Alzheimer's Research & Therapy (2023).